Morphocell Technologies completes US$50 million Series A financing, strengthening its foundation for growth in tissue therapeutics. This round was led by Investissement Québec and CDP Venture Capital.
Amount Raised
$50 Million
Round Type
Series A
LavalManufacturingBiotechnologyHealth CareInvestors
Description
Morphocell Technologies Inc. has announced the completion of its US$50 million Series A financing, which included a US$10 million add-on. This financing extension builds on the US$40 million Series A round from February 2024, marking significant progress in tackling liver disease. The support from Investissement Québec and CDP Venture Capital strengthens the company's operational runway
Quick answer
Morphocell Technologies raised $50 Million in a Series A round, dated December 1, 2025. Investors: Genson Capital, Investissement Québec and CDP Venture Capital. Morphocell Technologies is based in Laval, Quebec, Canada.
- How much did Morphocell Technologies raise?
- Morphocell Technologies raised $50 Million in a Series A round on December 1, 2025.
- Who invested in Morphocell Technologies?
- Genson Capital, Investissement Québec and CDP Venture Capital are named as investors in this round.
- What does Morphocell Technologies do?
- Morphocell Technologies Inc. is a regenerative medicine company focused on the development and commercialization of stem cell therapies and engineered tissue implants that target liver failure.
- Where is Morphocell Technologies based and how big is it?
- Morphocell Technologies is based in Laval, Quebec, Canada. Fundz records about 37 employees.
- Who are the decision-makers at Morphocell Technologies?
- Fundz holds 1 contact at Morphocell Technologies. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Manufacturing and Biotechnology around the same time
Companies in the same sectors as Morphocell Technologies that raised within 45 days of this round, from Fundz verified event records.
- Conavi Medical raised $700K (Seed) on January 13, 2026.
- Route 92 Medical raised $50M on January 13, 2026.
- Surgerii Robotics raised $100M (Series D) on January 7, 2026.
- Harvard Apparatus Regenerative Technology raised $700K on December 30, 2025.
- CASI Pharmaceuticals raised $5M on December 27, 2025.
- Kashiv BioSciences raised $72M (Debt Financing) on December 23, 2025.
Who to call at Morphocell Technologies, and when
A new round usually means Morphocell Technologies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Morphocell Technologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Morphocell Technologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Morphocell Technologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Morphocell Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansMorphocell Technologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.